Linked Data API

Show Search Form

Search Results

1387201
registered interest false more like this
date less than 2021-12-13more like thismore than 2021-12-13
answering body
Ministry of Justice more like this
answering dept id 54 more like this
answering dept short name Justice more like this
answering dept sort name Justice more like this
hansard heading Enforcement more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Justice, what steps the Government has taken to support the establishment of the Enforcement Conduct Authority proposed by Centre for Social Justice; and when his Department plans to publish the results of its 2018 call for evidence on enforcement agent reforms. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 91951 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-12-20more like thismore than 2021-12-20
answer text <p>The Ministry of Justice strongly supports the creation of the independent oversight body for enforcement agents and firms that has been proposed by the Centre for Social Justice (CSJ). Officials have met regularly with the CSJ and the working group that is establishing the body to support its development. We will undertake a review of the body within two years of its operation to see if any legislative changes are necessary to place it on a statutory footing.</p><p>The publication of the response to our call for evidence about the enforcement agent reforms, which closed in February 2019, has been delayed as a result of the department’s response to the pandemic. That allowed us to refocus our priorities, which resulted, for example, in MoJ and DLUHC introducing an extended ban on enforcing evictions to prevent people being made homeless during Covid, so protecting public health and easing the burden on the NHS and local authorities.</p><p>We remain committed to raising standards in this sector and will publish the response as soon as possible.</p>
answering member constituency South Suffolk more like this
answering member printed James Cartlidge more like this
question first answered
less than 2021-12-20T16:23:33.21Zmore like thismore than 2021-12-20T16:23:33.21Z
answering member
4519
label Biography information for James Cartlidge more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1353444
registered interest false more like this
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the size of the eligible population among severe asthma suffers for biologic treatments. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 44318 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-16more like thismore than 2021-09-16
answer text <p>No estimate has been made and information on the number of severe asthma patients are receiving biologic therapies is not available in the format requested.</p><p> </p><p> </p><p>Clinicians are responsible for making prescribing decisions for their patients, taking into account the National Institute for Health and Care Excellence’s technology appraisals and guidance on management of asthma and the local commissioning decisions. Prescribing of biologics for severe asthma is co-ordinated through severe asthma centre multi-disciplinary teams to ensure current treatments are optimised and all appropriate treatments are considered with use of biologics as part of the treatment review for each patient.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN
44319 more like this
44320 more like this
question first answered
less than 2021-09-16T15:01:18.38Zmore like thismore than 2021-09-16T15:01:18.38Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1353445
registered interest false more like this
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many severe asthma patients are receiving biologic therapies through (a) the severe asthma networks and (b) other services. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 44319 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-16more like thismore than 2021-09-16
answer text <p>No estimate has been made and information on the number of severe asthma patients are receiving biologic therapies is not available in the format requested.</p><p> </p><p> </p><p>Clinicians are responsible for making prescribing decisions for their patients, taking into account the National Institute for Health and Care Excellence’s technology appraisals and guidance on management of asthma and the local commissioning decisions. Prescribing of biologics for severe asthma is co-ordinated through severe asthma centre multi-disciplinary teams to ensure current treatments are optimised and all appropriate treatments are considered with use of biologics as part of the treatment review for each patient.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN
44318 more like this
44320 more like this
question first answered
less than 2021-09-16T15:01:18.417Zmore like thismore than 2021-09-16T15:01:18.417Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1353446
registered interest false more like this
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the geographical variation in the prescribing of biologics for severe asthma. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 44320 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-16more like thismore than 2021-09-16
answer text <p>No estimate has been made and information on the number of severe asthma patients are receiving biologic therapies is not available in the format requested.</p><p> </p><p> </p><p>Clinicians are responsible for making prescribing decisions for their patients, taking into account the National Institute for Health and Care Excellence’s technology appraisals and guidance on management of asthma and the local commissioning decisions. Prescribing of biologics for severe asthma is co-ordinated through severe asthma centre multi-disciplinary teams to ensure current treatments are optimised and all appropriate treatments are considered with use of biologics as part of the treatment review for each patient.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN
44318 more like this
44319 more like this
question first answered
less than 2021-09-16T15:01:18.463Zmore like thismore than 2021-09-16T15:01:18.463Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1353447
registered interest false more like this
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what help is available for asthma sufferers to enable them to continue to self-administer their medication due to the pressures on the NHS during the covid-19 outbreak. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 44321 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-10more like thismore than 2021-09-10
answer text <p>Specialist respiratory services for severe asthma, along with urgent and emergency treatment for other serious complaints, have continued throughout the COVID-19 outbreak. In most cases people with severe asthma have been able to receive their medication at home instead of having to attend hospital.</p><p>The National Institute for Health and Care Excellence COVID-19 rapid guideline on severe asthma promoted the use of home delivery for biologic treatments to maintain access and reduce the risks to patients of COVID-19 exposure. The NHS England severe asthma ‘Accelerated Access Collaborative’ will continue to focus on the area of home administration.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2021-09-10T13:13:49.163Zmore like thismore than 2021-09-10T13:13:49.163Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1353448
registered interest false more like this
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Coronavirus more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of covid-19 on people with asthma and severe asthma. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 44322 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-21more like thismore than 2021-09-21
answer text <p>As COVID-19 is a new disease, it is not yet clear what the physical, neurological, psychological and rehabilitation impacts will be for those with conditions such as asthma and severe asthma.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2021-09-21T16:51:52.663Zmore like thismore than 2021-09-21T16:51:52.663Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1353449
registered interest false more like this
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Coronavirus more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what the timescale is for patients with severe asthma who are shielding during the covid-19 outbreak and who have been taught to self-administer their medication at home to return to clinical supervision. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 44323 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-10more like thismore than 2021-09-10
answer text <p>People with severe asthma are not currently being asked to shield. The decision to continue self-administration of home biologics will be made between the person with severe asthma and their specialist centre on how best to manage their condition.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2021-09-10T13:15:25.833Zmore like thismore than 2021-09-10T13:15:25.833Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1348828
registered interest false more like this
date less than 2021-07-20more like thismore than 2021-07-20
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Community Diagnostic Centres more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what progress he has made on the roll out of asthma diagnostic hubs, set out in NICE Guidance NG80. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 36615 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-07-28more like thismore than 2021-07-28
answer text <p>Community Diagnostic Hubs (CDHs), which diagnose a number of conditions, will be launched in place of asthma diagnostic hubs. Diagnostics for respiratory conditions are part of the proposed ‘core’ services to be provided by CDHs. A review of diagnostics in the NHS Long Term Plan, highlighted that patients with respiratory symptoms would benefit from this facility due to the number of diagnostic tests that they use.</p><p>In 2021/22, £325 million has been allocated for diagnostic services. Discussions on how funding will be allocated are ongoing. Plans for mobilisation of CDHs from across England are currently under review. NHS England and NHS Improvement have approved the mobilisation of some early adopter sites from summer 2021 with more CDHs opening from autumn 2021.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2021-07-28T12:25:51.33Zmore like thismore than 2021-07-28T12:25:51.33Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1348829
registered interest false more like this
date less than 2021-07-20more like thismore than 2021-07-20
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Telemedicine more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of (a) the efficacy of remote consultations for asthma treatment and (b) the effect remote consultations has had on outcomes for asthma patients. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 36616 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-07-27more like thismore than 2021-07-27
answer text <p>No specific assessment has been made.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2021-07-27T15:31:56.037Zmore like thismore than 2021-07-27T15:31:56.037Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this
1348831
registered interest false more like this
date less than 2021-07-20more like thismore than 2021-07-20
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to support clinical choice in asthma treatment in the provision of biologic treatments, as recommended in the APPG report, entitled Improving Asthma Outcomes in the UK. more like this
tabling member constituency Makerfield more like this
tabling member printed
Yvonne Fovargue remove filter
uin 36617 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-07-27more like thismore than 2021-07-27
answer text <p>There has been significant increase in the use of biologics in the last three years. The decision to start a biologic treatment for asthma is made by specialist severe asthma multi-disciplinary teams (MDT) based in severe asthma centres on clinical grounds. The MDT considers all aspects of the patients’ illness, efficacy of current treatments and other treatment options. Patients receiving biologics are closely monitored to ensure that they are receiving the right treatment to help manage their symptoms.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2021-07-27T14:04:10.01Zmore like thismore than 2021-07-27T14:04:10.01Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4034
label Biography information for Yvonne Fovargue more like this